Please assess the completion status of the following clinical trial:

Trial Title: Study of Respiratory Depression When Using a Hydromorphone Pain Protocol

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Any patient who presents a condition that causes moderate to severe pain, according to the attending physician's judgment, in which the physician would order the use of parenteral analgesia~2. Able to provide consent.~Exclusion Criteria:~1. Patient or family member unable to consent~2. Altered mental status~3. SpO2 less than 95 percent~4. Allergy to opiates~5. Hypotension (Systolic blood pressure less than 90 mmHg)~6. Chronic oxygen dependency or known CO2 retention~7. Acute ETOH or drug intoxication~8. History of chronic pain syndrome or chronic use of opiate narcotics~9. History of opiate/heroin addiction, past or current.~10. End stage renal disease/dialysis patient~11. Chronic metabolic acidosis~12. Physician feels that patient would be poor candidate for study~13. Weight less than 100 pounds, all patients will be weighted~14. Patients younger than 60 years of age

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- 1mg + 1mg Hydromorphone (Type: ACTIVE_COMPARATOR): Patient will receive 1 mg of hydromorphone for pain at timepoint 0. After 15 minutes, patients will be asked if the still need pain medication. If yes, patients will immediately receive 1mg hydromorphone. Patients will be under continuous monitoring for respiratory depression via capnometer. At 60 minutes, pain will be re-assessed for a second time. If needed, physician will give additional pain meds per their discretion.
- Usual Care Group (Type: ACTIVE_COMPARATOR): Patient will receive pain medicine per doctor's discretion at timepoint 0. After 15 minutes, patients will be asked if they still need pain medication. If yes, physicians will not be notified and patient will continue to have pain managed as deemed necessary by physician per usual care. Patients will be under continuous monitoring for respiratory depression via capnometer. At 60 minutes, pain will be re-assessed for a second time. If needed, physician will give additional pain meds per their discretion.

Based on this trial design, predict the completion outcome and termination type (if applicable).